MX343948B - Compuestos de peroxido organico para inactivacion de microorganismos. - Google Patents

Compuestos de peroxido organico para inactivacion de microorganismos.

Info

Publication number
MX343948B
MX343948B MX2012012335A MX2012012335A MX343948B MX 343948 B MX343948 B MX 343948B MX 2012012335 A MX2012012335 A MX 2012012335A MX 2012012335 A MX2012012335 A MX 2012012335A MX 343948 B MX343948 B MX 343948B
Authority
MX
Mexico
Prior art keywords
organic peroxide
peroxide compounds
microorganism inactivation
inactivation
microorganism
Prior art date
Application number
MX2012012335A
Other languages
English (en)
Other versions
MX2012012335A (es
Inventor
Peter Gregersen Jens
Grundemann Thomas
Original Assignee
Novartis Ag *
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag * filed Critical Novartis Ag *
Publication of MX2012012335A publication Critical patent/MX2012012335A/es
Publication of MX343948B publication Critical patent/MX343948B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/02—Acyclic compounds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N35/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
    • A01N35/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aliphatically bound aldehyde or keto groups, or thio analogues thereof; Derivatives thereof, e.g. acetals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/24—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12061—Methods of inactivation or attenuation
    • C12N2720/12063—Methods of inactivation or attenuation by chemical treatment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16061—Methods of inactivation or attenuation
    • C12N2760/16063—Methods of inactivation or attenuation by chemical treatment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation
    • C12N2760/16163—Methods of inactivation or attenuation by chemical treatment

Abstract

La presente invención se refiere a peróxidos orgánicos multifuncionales como inactivadores microbiológicos y/o para degradar ácidos nucleicos. Éstos incluyen por lo menos un átomo de carbono y por lo menos dos grupos peróxido orgánicos. El inactivador es idealmente un hidroperóxido. La invención es particularmente útil durante la preparación de vacunas virales.
MX2012012335A 2010-05-06 2011-05-06 Compuestos de peroxido organico para inactivacion de microorganismos. MX343948B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39511710P 2010-05-06 2010-05-06
PCT/IB2011/001394 WO2011138682A2 (en) 2010-05-06 2011-05-06 Organic peroxide compounds for microorganism inactivation

Publications (2)

Publication Number Publication Date
MX2012012335A MX2012012335A (es) 2012-11-21
MX343948B true MX343948B (es) 2016-11-30

Family

ID=44532956

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012012335A MX343948B (es) 2010-05-06 2011-05-06 Compuestos de peroxido organico para inactivacion de microorganismos.

Country Status (11)

Country Link
US (1) US9426989B2 (es)
EP (1) EP2566323A2 (es)
JP (1) JP6072677B2 (es)
KR (1) KR20130079398A (es)
CN (1) CN102946727B (es)
AU (1) AU2011249487C1 (es)
BR (1) BR112012028146A2 (es)
CA (1) CA2796213A1 (es)
EA (1) EA201291179A1 (es)
MX (1) MX343948B (es)
WO (1) WO2011138682A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8883848B2 (en) 2011-07-14 2014-11-11 Ecolab Usa Inc. Enhanced microbial peracid compositions and methods of use at reduced temperatures in aseptic cleaning
US8906963B2 (en) 2011-07-14 2014-12-09 Ecolab Usa Inc Deodorization of peracids
GB2495341B (en) 2011-11-11 2013-09-18 Novartis Ag Fermentation methods and their products
ITUA20162517A1 (it) * 2016-04-12 2017-10-12 Andrea Fantozzi Composizione per la conservazione/fissazione di materiale biologico
CN110804641A (zh) * 2019-09-04 2020-02-18 中国农业科学院兰州兽医研究所 一种比较分析不同牛支原体菌株毒力的方法
KR20220098370A (ko) 2019-11-07 2022-07-12 세퀴러스 유케이 리미티드 감소된 입자 크기를 가지는 바이러스 백신을 제조하기 위한 조성물 및 방법

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL127618C (es) 1963-01-16
US3560395A (en) 1968-09-12 1971-02-02 Pennwalt Corp Aqueous ketone peroxide-hydrogen peroxide composition
US4060644A (en) * 1976-02-09 1977-11-29 Interox Chemicals Limited Bleaching
DE2933498A1 (de) * 1979-08-18 1981-04-09 Dr.rer.nat. Hans-Dieter 4234 Alpen Deppe Chemothermisches desinfektions- und sterilisationsverfahren
PH25669A (en) * 1985-12-19 1991-09-04 Padmini Sampathkumar Anaerobe-selective antibacterial compositions, methods
EP0461700A1 (en) * 1990-06-12 1991-12-18 Akzo Nobel N.V. Aqueous disinfectant compositions, and concentrates for preparing the same
US5437868A (en) * 1991-07-23 1995-08-01 Ecolab Inc. Peroxyacid antimicrobial composition
GB9222561D0 (en) * 1992-10-27 1992-12-09 Ici Plc Macromolecular degradation
US5824536A (en) * 1994-08-23 1998-10-20 St. Jude Children's Research Hospital Influenza virus replicated in mammalian cell culture and vaccine production
FR2738127B1 (fr) 1995-08-30 1998-03-27 Oreal Applicateur de mascara
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
GB9612035D0 (en) * 1996-06-08 1996-08-07 Oilfield Chemical Additives Li Method of inhibiting reservoir souring by bacteria
DE19817743A1 (de) * 1998-04-21 1999-10-28 Binker Materialschutz Gmbh Materialschutzmittel
AU758625B2 (en) 1998-08-20 2003-03-27 Ecolab Inc. The treatment of meat products
BR0014281A (pt) 1999-09-24 2002-05-21 Smithkline Beecham Biolog Vacina contra vìrus de gripe intranasal
WO2001064846A1 (en) 2000-03-03 2001-09-07 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Cell usable in serum-free culture and suspension culture and process for producing virus for vaccine by using the cell
FR2808803B1 (fr) 2000-05-11 2004-12-10 Agronomique Inst Nat Rech Cellules es modifiees et gene specifique de cellules es
GB0024089D0 (en) 2000-10-02 2000-11-15 Smithkline Beecham Biolog Novel compounds
US20020107288A1 (en) * 2000-12-08 2002-08-08 Singh Waheguru Pal Methods of sterilizing with dipercarboxylic acids
US7316824B2 (en) 2000-12-15 2008-01-08 Ecolab Inc. Method and composition for washing poultry during processing
JP5208347B2 (ja) 2001-02-23 2013-06-12 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 新規なワクチン
JP2004536785A (ja) 2001-02-23 2004-12-09 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 新規なワクチン
MY134424A (en) 2001-05-30 2007-12-31 Saechsisches Serumwerk Stable influenza virus preparations with low or no amount of thiomersal
US20030012804A1 (en) * 2001-06-22 2003-01-16 Aquacide And Use Aquacide and use
EP1420065A4 (en) * 2001-08-02 2005-03-09 Anges Mg Inc PROCESS FOR PRODUCING INACTIVE VIRAL ENVELOPES
DE10144903A1 (de) 2001-09-12 2003-03-27 Chiron Behring Gmbh & Co Vermehrung von Viren in Zellkultur
DE10144906B4 (de) 2001-09-12 2013-11-28 Novartis Vaccines And Diagnostics Gmbh Verfahren zur großtechnischen Herstellung von Impfstoffen
FR2832423B1 (fr) 2001-11-22 2004-10-08 Vivalis Systeme d'expression de proteines exogenes dans un systeme aviaire
CN1194984C (zh) * 2002-02-04 2005-03-30 中国农业科学院植物保护研究所 一种抗生素及其制备方法和应用
FR2836924B1 (fr) 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
JP4299514B2 (ja) * 2002-08-29 2009-07-22 長谷川香料株式会社 抗菌抗カビ剤
DE10306018A1 (de) * 2003-02-13 2004-09-09 Siemens Ag Analyse- und Diagnostikinstrument
CN1809388A (zh) * 2003-04-16 2006-07-26 新化学发展公司 二烷基酮过氧化物作为杀虫剂:杀菌、防腐、消毒和抗寄生剂的应用
EP1528101A1 (en) 2003-11-03 2005-05-04 ProBioGen AG Immortalized avian cell lines for virus production
WO2005113756A1 (en) 2004-05-14 2005-12-01 Glaxosmithkline Biologicals S.A. Method
CA2566858A1 (en) 2004-05-20 2005-12-01 Id Biomedical Corporation Process for the production of an influenza vaccine
CA2592120A1 (en) 2004-12-23 2006-07-06 Medimmune Vaccines, Inc. Non-tumorigenic mdck cell line for propagating viruses
GB0505909D0 (en) 2005-03-23 2005-04-27 Univ Leeds Formulations
FR2884255B1 (fr) 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
EP1942932B1 (en) * 2005-08-08 2013-05-08 Oregon Health and Science University Inactivating pathogens with hydrogen peroxide for vaccine production
WO2007042175A1 (en) * 2005-10-07 2007-04-19 Dsm Ip Assets B.V. Peroxide decomposition catalyst
ATE494906T1 (de) 2005-11-01 2011-01-15 Novartis Vaccines & Diagnostic Von zellen stammende virale impfstoffe mit geringen mengen an rest-zell-dna
ES2286949B1 (es) * 2006-05-26 2008-11-01 Braulio Peña Rodriguez Uso de combinaciones de peroxido de metil etil cetona por pulverizacion.
EA200900784A1 (ru) 2006-12-06 2009-12-30 Новартис Аг Вакцины, включающие антиген из четырех штаммов вируса гриппа

Also Published As

Publication number Publication date
AU2011249487B2 (en) 2014-10-02
CN102946727A (zh) 2013-02-27
EA201291179A1 (ru) 2013-04-30
KR20130079398A (ko) 2013-07-10
US9426989B2 (en) 2016-08-30
WO2011138682A3 (en) 2012-03-15
JP6072677B2 (ja) 2017-02-01
AU2011249487A1 (en) 2012-09-27
BR112012028146A2 (pt) 2015-09-15
MX2012012335A (es) 2012-11-21
AU2011249487C1 (en) 2015-05-14
WO2011138682A8 (en) 2012-07-19
JP2013528586A (ja) 2013-07-11
CA2796213A1 (en) 2011-11-10
EP2566323A2 (en) 2013-03-13
US20130149194A1 (en) 2013-06-13
CN102946727B (zh) 2015-08-19
WO2011138682A2 (en) 2011-11-10

Similar Documents

Publication Publication Date Title
MX343948B (es) Compuestos de peroxido organico para inactivacion de microorganismos.
PH12015501017A1 (en) Alternative uses for hbv assembly effectors
PH12015500347A1 (en) 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
WO2011005595A3 (en) 2-5a analogs and their methods of use
MX2012008738A (es) Microorganismos y metodos para la biosintesis de p-toluato y tereftalato.
WO2011144344A3 (en) Appliance for at least partially sterilizing a contaminated surface
WO2011135246A3 (fr) Emballage pour objet et ensemble comprenant un tel emballage
NZ721520A (en) Novel 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
EA025278B9 (ru) Антивирусная композиция против заключенных или незаключенных в оболочку днк- или рнк-вирусов
WO2012006149A3 (en) Analogs of c5a and methods of using same
NZ607996A (en) Substituted nucleotide analogs
WO2013181647A3 (en) Compositions and methods of producing isoprene and/or industrrial bio-products using anaerobic microorganisms
SG179566A1 (en) Hcv protease inhibitors
WO2009002772A3 (en) Bioreactor
CA2798214C (en) Vaccine against beta-herpesvirus infection and use thereof
PH12015501637A1 (en) Inactivated dengue virus vaccine with aluminium-free adjuvant
MY161252A (en) Viral inactivation using improved solvent-detergent method
WO2012019299A9 (en) Hepatitis c inhibitor compounds
MX2011007401A (es) Isomerizacion de 1, 1, 3, 3-tetrafluoropropeno.
WO2013009910A3 (en) Eosinophil peroxidase compositions and methods of their use
MX2012007341A (es) Inhibidores de proteasoma y procesos para su preparacion, purificacion y uso.
AU2013318309A8 (en) Methods for treating hepatitis C
WO2011029536A3 (de) Verwendung von cyclischen ketoenolen gegen pflanzenpathogene bakterien
BR112017000846A2 (pt) bactérias termofílicas geneticamente modificadas que produzem ácido (r)-láctico
MX348758B (es) Derivados de sanglifehrina y metodos para su produccion.

Legal Events

Date Code Title Description
FG Grant or registration